bird flu

▪ disease

also called  avian influenza 

 a viral respiratory disease (see respiratory disease: Viral infections (respiratory disease)) mainly of poultry and certain other bird species, including migratory waterbirds, some imported pet birds, and ostriches, that can be transmitted directly to humans. The first known cases in humans were reported in 1997, when an outbreak in poultry in Hong Kong led to severe illness in 18 people, a third of whom died. Symptoms of bird flu in humans resemble those of the human variety of influenza and include fever, sore throat, cough, headache, and muscle aches, which appear following an incubation period of several days. Severe infection can result in conjunctivitis or such life-threatening complications as bacterial or viral pneumonia and acute respiratory illness. Between 2003 and late 2005, outbreaks of the most deadly variety of bird flu occurred among poultry in Cambodia, China, Indonesia, Japan, Kazakhstan, Laos, Malaysia, Romania, Russia, South Korea, Thailand, Turkey, and Vietnam. Hundreds of millions of birds in those countries died from the disease or were killed in attempts to control the epidemics. From 2003 through January 2009, 397 people were reported to have been infected with bird flu, and slightly less than two-thirds of them died. The majority of human infections and deaths occurred in China, Egypt, Indonesia, Thailand, and Vietnam. Poultry-associated human infection with a less severe form of the disease was reported in The Netherlands.

      Bird flu in avian species occurs in two forms, one mild and the other highly virulent and contagious; the latter form has been termed fowl plague. Mutation of the virus causing the mild form is believed to have given rise to the virus causing the severe form. The infectious agents of bird flu are any of several subtypes of type A orthomyxovirus. Other subtypes of this virus are responsible for most cases of human influenza and for the great influenza pandemics of the past (see influenza epidemic of 1918–19). Genetic analysis suggests that the influenza A subtypes that afflict mainly nonavian animals, including humans, pigs, whales, and horses, derive at least partially from bird flu subtypes. All the subtypes are distinguished on the basis of variations in two proteins found on the surface of the viral particle—hemagglutinin (H) and neuraminidase (N). The 1997 bird flu outbreak in Hong Kong was found to be caused by H5N1. This subtype, first identified in terns in South Africa in 1961, has been responsible for nearly all laboratory-confirmed bird flu infections in humans and for the most devastating outbreaks in poultry. Other bird flu subtypes recognized to cause disease in birds and humans are H7N2, H7N3, H7N7, and H9N2.

       waterfowl such as wild ducks are thought to be primary hosts for all bird flu subtypes. Though normally resistant to the viruses, the birds carry them in their intestines and distribute them through feces into the environment, where they infect susceptible domestic birds. Sick birds pass the viruses to healthy birds through saliva, nasal secretions, and feces. Within a single region, bird flu is transmitted readily from farm to farm by airborne, feces-contaminated dust and soil, by contaminated clothing, feed, and equipment, or by wild animals carrying the virus on their bodies. The disease is spread from region to region by migratory birds and through international trade in live poultry. Humans who are in close contact with sick birds—for example, poultry farmers and slaughterhouse workers—are at the greatest risk of becoming infected. Virus-contaminated surfaces and intermediate hosts such as pigs can also be sources of infection for humans. Although isolated instances of person-to-person transmission appear to have occurred since 1997, sustained transmission has not been observed. However, through a rapid evolutionary process called antigenic shift, two viral subtypes—e.g., one a bird flu virus such as H5N1 and the other a human influenza virus—can combine parts of their genetic makeup to produce a previously unknown viral subtype. If the new subtype causes severe disease in humans, spreads easily between people, and has a combination of surface proteins to which few people have immunity, the stage will be set for a new influenza pandemic to occur.

      Early detection of avian influenza is important in preventing and controlling outbreaks. One way the virus can be detected is by polymerase chain reaction (PCR), in which nucleic acids from blood or tissue samples are analyzed for the presence of molecules specific to bird flu. Other methods include viral antigen detection, which detects the reaction of antibodies to viral antigens in samples of skin cells or mucus, and viral culture, which is used to confirm the identity of specific subtypes of influenza based on the results of PCR or antigen detection and requires growth of the virus in cells in a laboratory. Tests based on lab-on-a-chip technology that take less than an hour to complete and can accurately identify specific subtypes of bird flu are being developed. This technology consists of a small device (the “chip”) that contains on its surface a series of scaled-down laboratory analyses requiring only a tiny volume of sample (e.g., picolitres of saliva). These chip-based tests, which are portable and cost-effective, can be used to detect different subtypes of influenza in both poultry and humans.

      Because of the many immunologically distinct viral subtypes that cause influenza in animals and the ability of the virus to rapidly evolve new strains, preparation of effective vaccines is complicated. The most effective control of outbreaks in poultry remains rapid culling of infected farm populations and decontamination of farms and equipment. This measure also serves to reduce the chances for human exposure to the virus. In 2007 the U.S. Food and Drug Administration approved a vaccine to protect humans against one subtype of the H5N1 virus. It was the first vaccine approved for use against bird flu in humans. Drug manufacturers and policy makers in developed and developing countries are working toward establishing a stockpile of the vaccine to provide some measure of protection against a future outbreak of bird flu. In addition, scientists are developing a vaccine that is effective against another subtype of H5N1, as well as a vaccine that might protect against all subtypes of H5N1. Studies suggest that antiviral drugs (drug) developed for human flu viruses would work against bird flu infection in humans. The H5N1 virus, however, appears resistant to at least two of the drugs, amantadine and rimantadine.

* * *